The report on Global Erythropoietin (EPO) Drugs Market added by Reports and Data offers a comprehensive analysis of the recent advancements in the Erythropoietin (EPO) Drugs industry and trends driving the growth of the market.
Share: email Subscribe
Weekly Top Stories Tue, 16 Aug 2022
We have 19 articles this week. #TRON Group, Inc. and #Nanopharmaceutics, Inc. Announce Definitive Merger Agreement. #Disc Absorbs #Gemini in Bid to Propel Hematology Pipeline. #OceanTech Acquisitions I Corp. and #CapturaBiopharma, Inc. Announce Signing of Definitive Business Combination Agreement. #GeminiTherapeutics and #DiscMedicine Announce Merger Agreement. #Emergent Acquires #EvolutionaryBiologics, Former L’Oréal President Jim Morrison to Become Full Time CEO of Emergent Effective August 15, 2022. #908Devices Acquires #TRACEAnalytics, Enabling On-line Bioanalytics. #CONMED Completes Acquisition of #Biorez, Inc.. #EaglePharmaceuticals Takes Equity Stake in, with Option to Acquire, #EnalareTherapeutics to Advance Global Development of ENA-001, a Novel Agnostic Respiratory Stimulant. #Catalent to Acquire #MetricsContractServices for $475 Million to Expand High-Potent Capabilities and Oral Development and Manufacturing Capacity. #Pfizer Doubles Down on Sickle Cell Disease with $5.4B #GlobalBloodTherapeutics Buy.
Editor's Choice
1. 
Erythropoietin (EPO) Drugs Market Size and Analysis, Trends, Recent Developments, and Forecast Till 2026
2. 
Blood Plasma Market is Expected to Clock a Notable 10.60% CAGR During 2022-2029: Profiling Companies & Growth Strategies
3. 
Artificial Intelligence in Drug Discovery Global Market Report 2022: Rise in Demand for a Reduction in the Overall Time Taken for the Drug Discovery Process is a Key Driver Propelling Growth – ResearchAndMarkets.com
4. 
Biostimulants Market Size Worth US$ 5.8 Billion By 2028 at 10.9% CAGR with Global Analysis of 18+ Countries Across 5 Key Regions, 50+ Companies Scrutinized By the Insight Partners
5. 
Global Pharma and Biotech CRM Software Market Report 2022: Extensive Capacity of Digital Health Applications and Their Potential in the Healthcare Industry is Attracting Investment and Fueling Growth
Top 10 M&A Transactions
6. 
TRON Group, Inc. and Nanopharmaceutics, Inc. Announce Definitive Merger Agreement
7. 
Disc Absorbs Gemini in Bid to Propel Hematology Pipeline
8. 
Oceantech Acquisitions I Corp. and Captura Biopharma, Inc. Announce Signing of Definitive Business Combination Agreement
9. 
Gemini Therapeutics and Disc Medicine Announce Merger Agreement
10. 
Emergent Acquires Evolutionary Biologics, Former L’Oréal President Jim Morrison to Become Full Time CEO of Emergent Effective August 15, 2022
11. 
908 Devices Acquires TRACE Analytics, Enabling On-Line Bioanalytics
12. 
CONMED Completes Acquisition of Biorez, Inc.
13. 
Eagle Pharmaceuticals Takes Equity Stake In, with Option to Acquire, Enalare Therapeutics to Advance Global Development of ENA-001, a Novel Agnostic Respiratory Stimulant
14. 
Catalent to Acquire Metrics Contract Services for $475 Million to Expand High-Potent Capabilities and Oral Development and Manufacturing Capacity
15. 
Pfizer Doubles Down on Sickle Cell Disease with $5.4B Global Blood Therapeutics Buy
Top 1 Venture Funding
16. 
Indonesian Digital Derma Startup Diri Care Scores $4.3M in Seed Funding
Top 2 Partnerships Announcements
17. 
Top Academic Health System Partners with Scanslated, Inc. to Offer Patient-Friendly Radiology Reports
18. 
Ginkgo Bioworks and the Rwanda Development Board Announce Plans to Develop and Implement New Biosecurity Capabilities in Rwanda
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us